Pharming Group N.V. welcomes new Chief People Officer
Other updatesPharming Group N.V. is pleased to welcome Inés Bernal as our new Chief People Officer (CPO) and member of the Executive Committee as of December 1, 2024.
Pharming Group N.V. is pleased to welcome Inés Bernal as our new Chief People Officer (CPO) and member of the Executive Committee as of December 1, 2024.
Pharming Group N.V. is pleased to announce its recognition as an Industry Innovator by the National Organization for Rare Disorders (NORD®) at the Rare Impact Awards on June 8, 2024.
By: Anurag Relan, Pharming Chief Medical Officer
A conversation with Sarah, mom to Tyler and Kaitlyn, who are living with a rare disease known as APDS
On February 11, Pharming celebrates the International Day of Women and Girls in Science, which was first declared by the United Nations in 2015 to promote the full and equal access to, and participation of, women and girls in Science, Technology, Engineering and Mathematics (STEM) fields. The day promotes the role of women in scientific fields, promoting those already successful in the field, and aims to inspire more women and girls to pursue careers in science.
There’s strength in the stories of people living with rare diseases.
Pharming shortlisted in two categories, including “Biotech Company of the Year” and “Best New Drug”
Pharming is delighted to announce that CEO Sijmen de Vries was the winner of the Chief Executive of the Year Award at the 2023 European Mediscience Awards in London on Thursday evening. Scroll down for the Dutch translation.
We are deeply saddened to announce the passing of our former Chairman Drs. Jakob (Jaap) Blaak.
Pharming Group N.V. supports the 10th annual “hae-day :-)”, the global awareness day for hereditary angioedema (HAE), a rare life-threatening condition.
Wilt u overschakelen naar een andere taal? Klik hier voor de Nederlandse website.